# Question 57

**Type:** Out of scope

**Question:** For patients with the EML4-ALK fusion gene in lung cancer how do the different fusion variants affect their long-term quality of life and risk of developing a secondary cancer?

**Answer:**

**URL**: https://www.cbioportal.org/results/oncoprint?Action=Submit&RPPA_SCORE_THRESHOLD=2.0&Z_SCORE_THRESHOLD=2.0&cancer_study_list=luad_tcga_pan_can_atlas_2018&case_set_id=luad_tcga_pan_can_atlas_2018_cnaseq&data_priority=0&gene_list=EML4-ALK&geneset_list=%20&genetic_profile_ids_PROFILE_COPY_NUMBER_ALTERATION=luad_tcga_pan_can_atlas_2018_gistic&genetic_profile_ids_PROFILE_MUTATION_EXTENDED=luad_tcga_pan_can_atlas_2018_mutations&profileFilter=0&tab_index=tab_visualize

I've routed you to the cBioPortal lung adenocarcinoma study (TCGA PanCancer Atlas 2018) with EML4-ALK queried. This will show you patients with alterations in these genes.

**Important limitations:**
- cBioPortal does **not contain quality of life data** or information about secondary cancer development
- cBioPortal focuses on genomic alterations, clinical outcomes (survival), and molecular profiles from the original tumor samples

**What you CAN explore on this page:**
- Identify patients with EML4-ALK fusions in the OncoPrint view
- Access clinical data including survival outcomes (overall and disease-free survival)
- Compare mutation patterns and co-occurring alterations between patients with different fusion variants
- Use the "Clinical" tab to see available clinical attributes

**What is NOT available:**
- Specific fusion variant breakpoint information (e.g., variant 1, 3a, 3b)
- Quality of life metrics
- Secondary cancer incidence data
- Long-term follow-up beyond survival endpoints

For detailed fusion variant analysis and quality of life correlations, you would need to consult primary literature or clinical trial databases that specifically track these endpoints.

---

## Model Information
- **model**: us.anthropic.claude-sonnet-4-5-20250929-v1:0
- **temperature**: 0.0
- **max_output_tokens**: 1024
- **thinking_enabled**: False
- **thinking_budget_tokens**: 1024
- **response_time_seconds**: 11.443334519979544
- **agent_type**: cbio-nav-null

### Usage
- **input_tokens**: 564
- **output_tokens**: 479
- **total_tokens**: 1043
- **cache_creation_input_tokens**: 0
- **cache_read_input_tokens**: 0

---

*Generated on 2026-02-05 01:41:39*